BRIEF-Enanta Pharmaceuticals Q1 Revenue USD 16.959 Million

Reuters
11 Feb
BRIEF-Enanta Pharmaceuticals Q1 Revenue USD 16.959 Million

Feb 10 (Reuters) - Enanta Pharmaceuticals Q1 operating expenses USD 40.502 million.

  • Q1 pretax profit USD -22.706 million
  • Q1 net income USD -22.29 million
  • Q1 operating income USD -23.543 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10